Chemo regimen can limit Herceptin heart risk-study
8th Dec 2005, 21:09 GMT
LOS ANGELES (Reuters) - The breast cancer drug Herceptin, shown recently to improve survival in women with early-stage breast cancer, carries with it a risk of heart damage, but a chemotherapy regimen can limit the danger, researchers said on Thursday.
Chemo regimen can limit Herceptin heart risk-study related news:
- Chemo regimen can limit Herceptin heart risk-study (Reuters) — Yahoo! News: Health News
- Chemo regimen can limit Herceptin heart risk-study — RedOrbit News - Health
- Interim Analysis of Phase III Study Shows TAXOTERE Based Regimens With HERCEPTIN Significantly Improved Disease Free Survival in Women With Early-Stage HER2-Positive Breast Cancer — Mammography News from StratCenter.com
- HERCEPTIN 'CUTS RISK' OF CANCER — Mirror.co.uk - News - Top Stories
- Breast cancer drug halves return risk — the Mail online | Health
- More disturbing evidence in Vioxx case — The Cardio Blog
- Combining herceptin with chemotherapy improves survival in breast cancer — KeralaNext: Health
- Heart study holds therapy promise — azcentral.com | scottsdale
- Dose-dense Chemotherapy For Early Breast Cancer Found Safe, Similar To Standard Regimen — ScienceDaily Headlines: Health & Medicine
- Herceptin proving to be a wonder drug — The Cardio Blog
Latest news from Reuters: Health:
- Blow to chest can be fatal in child athletes: study
- Two Canada professors win right to toke up at work
- Diabetes drug may cut heart risks: study
- Most U.S. women in the dark about HPV: survey
- Red meat linked to some breast cancers: study
- Weight-loss surgery safety varies drastically: study
- Flu shot linked to tiny rise in risk for ailment
- Human natural painkiller beats morphine: research
- Radioactive iodine linked to thyroid disease
- Children showing hardening of arteries: study